Kristie Christensen, NP
Primary Care · Salt Lake City, UTNPI 1407373574
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 20 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Si-bone, Inc. at 28.1% of the total. Reporting peaked in 2023 at $246 and has fallen 93.5% since, to $16 in 2025. That places this record below the midpoint for primary care clinicians in UT, where the typical reported total is $461.
Across 20 payments — averaging $26.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Si-bone, Inc.$150
- Medtronic$128
- Boston Scientific$67
- AbbVie$37
- Johnson & Johnson$33
- Exeltis, USA Inc.$29
- plus $91 from 6 others
What the payments were for
- Food & beverage$535100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Si-bone, Inc. | 2 | $150 |
| Medtronic | 5 | $128 |
| Boston Scientific | 3 | $67 |
| AbbVie | 2 | $37 |
| Johnson & Johnson | 1 | $33 |
| Exeltis, USA Inc. | 1 | $29 |
| SPR Therapeutics, Inc | 1 | $17 |
| Relievant Medsystems, Inc. | 1 | $17 |
| Indivior Inc. | 1 | $16 |
| Stryker | 1 | $15 |
| Boehringer Ingelheim | 1 | $13 |
| Braeburn Inc. | 1 | $13 |
How this compares
$535 in reported general payments places this provider in the 50th percentile of 60 primary care providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 40 | $445 |
| Methocarbamol | 34 | $282 |
| Methylprednisolone | 32 | $249 |
| Oxycodone Hcl | 22 | $232 |
| Cyclobenzaprine Hcl | 28 | $229 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 19 | $207 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $157 |
| Tizanidine Hcl | 13 | $144 |
| Diclofenac Sodium | 14 | $106 |
| Tramadol Hcl | 19 | $93 |
Paid to pharmacies, not to this prescriber.
Other primary care in Salt Lake City
- Catherine CoatesSalt Lake City$5K
- Madeleine RupertSalt Lake City$3K
- Jacqueline LobsigerSalt Lake City$1K
- Megan KalraSalt Lake City$878
- Margaret GroganSalt Lake City$694
- Jennifer McCulloughSalt Lake City$295
- Matthew AndersonSalt Lake City$126
- Dayne TattersallSalt Lake City$88
- Suzanne TalkenSalt Lake City$38
- James ViskerSalt Lake City$30
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.